Trends in rheumatic fever: clinical aspects and perspectives in prophylactic treatments

Silva, Káttya Gyselle de Holanda e; Barratt, Gillian; Oliveira, Anselmo Gomes de; Egito, Eryvaldo Sócrates Tabosa do

doi:10.1517/17425247.2012.702104

Cited by 2 publications

(2 citation statements)

References 101 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…69 Implantable or nanocarrier-based delivery of BPG would be a potential alternative to monthly injection, but innovation has been limited in this field. 29,70 Approaches to optimize compliance with secondary prophylaxis remain important research questions. For example, a community randomized trial in the Aboriginal population in Australia is currently being conducted to evaluate a health service intervention aimed at improving adherenc e rates to s econdary pr ophylaxis.…”

Section: Secondary Preventionmentioning

confidence: 99%

Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease

et al. 2013

View full text Add to dashboard Cite

In the 21(st) century, rheumatic fever (RF) and rheumatic heart disease (RHD) are neglected diseases of marginalized communities. Globally, RHD remains the most-common cardiovascular disease in young people aged <25 years. Although RF and RHD have been almost eradicated in areas with established economies, migration from low-income to high-income settings might be responsible for a new burden of RHD in high-income countries. The World Heart Federation (WHF) and its Working Group on RF and RHD unites global experts, combines their experience and enthusiasm, and provides a platform for RHD control. This paper is a declaration of the WHF institutional strategic goal--a 25% reduction in premature deaths from RF and RHD among individuals aged <25 years by the year 2025. The position statement affirms WHF commitments to five key strategic targets: comprehensive register-based control programmes, global access to benzathine penicillin G, identification and development of public figures as 'RHD champions', expansion of RHD training hubs, and support for vaccine development. In this paper, we also review existing barriers to RF and RHD control and identify the actions required to change the trajectory of control for these diseases. This approach provides the foundation for governments, civil society, patient advocates, clinicians, researchers, and funding agencies to develop partnerships and unify global efforts to control RF and RHD. The WHF plans to expand this position statement to an operational plan that will be founded on science, research, and quantifiable progress indicators to impact positively on the millions of people who are affected by RHD and its long-term sequelae.

show abstract

Section: Secondary Preventionmentioning

confidence: 99%

Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease

et al. 2013

View full text Add to dashboard Cite

show abstract

“…В литера-туре последних лет активно обсуждаются возможности со-здания новых лекарственных форм бензатин-пенициллина на основе нанотехнологий, в частности, микроэмульсий и мицеллярных систем. Полагают, что внедрение данных технологий обеспечит явные преимущества, касающиеся в первую очередь фармакокинетики препарата, но это -дело ближайшего будущего [12].…”

Section: Acute Rheumatic Fever In the 21st Century: The Problem That unclassified

ACUTE RHEUMATIC FEVER IN THE 21st CENTURY: THE PROBLEM THAT CANNOT BE FORGOTTEN

Кузьмина¹,

Белов²,

Медынцева³

2016

rsp

View full text Add to dashboard Cite

Trends in rheumatic fever: clinical aspects and perspectives in prophylactic treatments

Cited by 2 publications

References 101 publications

Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease

Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease

ACUTE RHEUMATIC FEVER IN THE 21st CENTURY: THE PROBLEM THAT CANNOT BE FORGOTTEN

Contact Info

Product

Resources

About